GLICLAZIDA TERAPIA 60 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

gliclazida terapia 60 mg

terapia s.a. - gliclazidum - compr. elib. mod. - 60mg - antidiabetice orale sulfonamide

ESQUEL 80 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

esquel 80 mg

gedeon richter romania s.a. - romania - gliclazidum - compr. - 80mg - antidiabetice orale si parenterale , exclusiv insuline sulfonamide, derivati de uree

GLYCLADA 30 mg România - română - ANMDM (Agentia Nationala a Medicamentului si a Dispozitivelor Medicale)

glyclada 30 mg

krka, d.d., novo mesto - slovenia - gliclazidum - compr. cu elib. prel. - 30mg - antidiabetice orale si parenterale , exclusiv insuline sulfonamide

Galvus Uniunea Europeană - română - EMA (European Medicines Agency)

galvus

novartis europharm limited - vildagliptin - diabetul zaharat, tip 2 - medicamente utilizate în diabet - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Jalra Uniunea Europeană - română - EMA (European Medicines Agency)

jalra

novartis europharm limited - vildagliptin - diabetul zaharat, tip 2 - dipeptidyl peptidase 4 (dpp-4) inhibitors, drugs used in diabetes - vildagliptin is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:as monotherapy in patients in whom metformin is inappropriate due to contraindications or intolerance. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 și 5. 1 pentru datele disponibile pe diferite combinații).